Are Psoriasis and PsA Underdiagnosed in Underserved Groups? Are Psoriasis and PsA Underdiagnosed in Underserved Groups?
Underserved groups in the United States may be underdiagnosed because of a lack of access to healthcare, researchers report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 12, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Causal Link Suggested for Psoriasis, Cardiovascular Disease
THURSDAY, Aug. 11, 2022 -- Evidence suggests a potential causal link for psoriasis and cardiovascular disease (CVD), according to a study published online June 29 in Frontiers in Immunology.
Ning Gao, from The Second Affiliated Hospital of Zhejiang... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 11, 2022 Category: Pharmaceuticals Source Type: news
Study: Flares in Pustular Psoriasis Often Undertreated
(MedPage Today) -- Many patients with generalized pustular psoriasis (GPP) flares got no specific treatment for them, despite their high risk of severe complications, according to the biggest study of these episodes to date.
Among 1,535 patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 10, 2022 Category: Dermatology Source Type: news
Dermatologist Visits Shorter for Asian Psoriasis Patients
MONDAY, Aug. 8, 2022 -- Asian patients with psoriasis receive significantly less face-to-face time with a dermatologist than patients of other races and ethnicities, according to a research letter published online Aug. 3 in JAMA Dermatology.
Kevin... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 8, 2022 Category: Pharmaceuticals Source Type: news
Mayo Clinic Minute: Fingernails are clues to your health
Psoriasis can affect fingernails and toenails, causing pitting, abnormal growth and discoloration. August is Psoriasis Awareness Month. And experts at Mayo Clinic say it's important to keep an eye on your nails, as they can provide clues to your overall health. Watch: The Mayo Clinic Minute https://youtu.be/4UE0YtSSeUg Journalists: Broadcast-quality video pkg (1:00) is in the downloads at the end of the post. Please courtesy: "Mayo Clinic News Network." Read the script. Many people develop lines or… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 5, 2022 Category: Databases & Libraries Source Type: news
Asian Psoriasis Patients Get Less Time With Dermatologists, Study Suggests
(MedPage Today) -- Asian patients with psoriasis receive less face-to-face time with dermatologists, according to a cross-sectional study.
Among over 4 million patient visits for psoriasis, mean duration of visit was 9.2 minutes for Asian patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 3, 2022 Category: Dermatology Source Type: news
Asian patients with psoriasis get less time at dermatologist visit, study says
Asian patients with psoriasis have much shorter visits with their dermatologists compared with patients of other races and ethnicities, a study released Wednesday suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 3, 2022 Category: Consumer Health News Source Type: news
Episode 6: Biologics in Psoriasis: A Spectacular Run Episode 6: Biologics in Psoriasis: A Spectacular Run
Host Dr Steven Feldman unpacks years of accrued knowledge on managing psoriasis using biologic therapy, with our special guest Dr Craig Leonardi.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 3, 2022 Category: Consumer Health News Tags: Dermatology InDiscussion Source Type: news
Ustekinumab Becomes Second Biologic Approved for PsA in Kids Ustekinumab Becomes Second Biologic Approved for PsA in Kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to severe plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 2, 2022 Category: Dermatology Tags: Rheumatology News Alert Source Type: news
Topical PDE4 Inhibitor for Plaque Psoriasis Passes Muster With FDA
(MedPage Today) -- The FDA approved the topical PDE4 inhibitor roflumilast (Zoryve) for mild-to-severe plaque psoriasis, including for intertriginous areas, in patients ages 12 years and older, Arcutis Biotherapeutics announced.
Roflumilast cream... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 1, 2022 Category: American Health Source Type: news
STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis
A topical formulation of a PDE4 inhibitor approved for treating COPD has been approved for treatment of plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 30, 2022 Category: Dermatology Tags: Dermatology News Alert Source Type: news
FDA Approves Zoryve (roflumilast) Cream for the Treatment of Plaque Psoriasis
WESTLAKE VILLAGE, Calif., July 29, 2022 (GLOBE NEWSWIRE)— Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 29, 2022 Category: Drugs & Pharmacology Source Type: news
Psoriasis Questionnaire Might Identify Risk of Axial Disease Psoriasis Questionnaire Might Identify Risk of Axial Disease
A patient-completed questionnaire shows promise for detecting risk of undiagnosed axial involvement in psoriasis.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 26, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
NAFLD Strongly Correlated With Psoriasis, PsA NAFLD Strongly Correlated With Psoriasis, PsA
The 11 observational studies included in the meta-analysis met stringent criteria, including a diagnosis of psoriasis and PsA based on objective criteria, and NAFLD confirmed with liver biopsy or imaging.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2022 Category: Consumer Health News Tags: Dermatology News Source Type: news
